---
title: Frequency of Xerostomia and Their Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy
nct_id: NCT02857413
overall_status: COMPLETED
sponsor: Centre Hospitalier Universitaire de Besancon
study_type: OBSERVATIONAL
primary_condition: Head and Neck Neoplasms
countries: France
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02857413.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02857413"
ct_last_update_post_date: 2016-08-08
last_seen_at: "2026-05-12T06:55:02.313Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Frequency of Xerostomia and Their Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy

**Official Title:** Assessment of Frequency of Xerostomia and Their Care Management in Upper Aerodigestive Tract Cancer Patients After the End of Radiotherapy

**NCT ID:** [NCT02857413](https://clinicaltrials.gov/study/NCT02857413)

## Key Facts

- **Status:** COMPLETED
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 42
- **Lead Sponsor:** Centre Hospitalier Universitaire de Besancon
- **Conditions:** Head and Neck Neoplasms
- **Start Date:** 2016-01
- **Completion Date:** 2016-07
- **CT.gov Last Update:** 2016-08-08

## Brief Summary

The aim of this study is the evaluation of the frequency of xerostomia and their management after radiotherapy in head and neck cancer.

The quality of life of these patients is also analysed with European Organization for Research and Treatment of Cancer Quality of life Questionnaire H\&N35 (EORTC QLQ H\&N35).

## Eligibility

- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* patient with head and neck cancer after radiotherapy treatment

Exclusion Criteria:

* patient already treated for xerostomia for other reason : Sjögren's syndrome, medication, diabetes,...
```

## Primary Outcomes

- **Frequency of xerostomia and their management after radiotherapy in head and neck cancer** _(time frame: at enrollment)_ — patients describe the severity of their xerostomia and their management in a standardized questionnaire

## Secondary Outcomes

- **quality of life af patients after radiotherapy in head and neck cancer** _(time frame: at enrollment)_

## Locations (1)

- CHU Besançon, Besançon, France

## Recent Field Changes (last 30 days)

- `results.hasResults` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `locations.chu besançon|besançon||france` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02857413.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02857413*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*